Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

Docetaxel plus cisplatin and docetaxel plus irinotecan are active and well-tolerated chemotherapy regimens for advanced non-small-cell lung cancer (NSCLC). A randomised phase II study compared their efficacy and toxicity in 108 patients with stage IIIb/IV NSCLC, who were randomised to receive doceta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yamamoto, N, Fukuoka, M, Negoro, S-I, Nakagawa, K, Saito, H, Matsui, K, Kawahara, M, Senba, H, Takada, Y, Kudoh, S, Nakano, T, Katakami, N, Sugiura, T, Hoso, T, Ariyoshi, Y
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2004
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395326/
https://ncbi.nlm.nih.gov/pubmed/14710212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601462
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados